Xylem (NYSE:XYL) PT Raised to $135.00 at Mizuho

Xylem (NYSE:XYL) had its price target boosted by research analysts at Mizuho from $110.00 to $135.00 in a report issued on Friday, Benzinga reports. The firm presently has a “neutral” rating on the industrial products company’s stock. Mizuho’s price objective indicates a potential downside of 1.61% from the stock’s current price.

XYL has been the topic of several other reports. Stifel Nicolaus boosted their target price on Xylem from $136.00 to $150.00 and gave the stock a “buy” rating in a report on Wednesday, February 7th. BNP Paribas began coverage on Xylem in a report on Tuesday, March 12th. They set an “outperform” rating and a $150.00 target price on the stock. Citigroup boosted their target price on Xylem from $126.00 to $139.00 and gave the stock a “neutral” rating in a report on Monday, April 8th. Raymond James upgraded Xylem from an “underperform” rating to a “market perform” rating in a report on Thursday, January 4th. Finally, Royal Bank of Canada boosted their target price on Xylem from $140.00 to $145.00 and gave the stock an “outperform” rating in a report on Wednesday, February 7th. Five analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to data from MarketBeat.com, Xylem currently has a consensus rating of “Moderate Buy” and a consensus target price of $140.70.

Xylem Price Performance

NYSE:XYL opened at $137.21 on Friday. Xylem has a 12 month low of $87.59 and a 12 month high of $138.46. The stock has a 50 day moving average of $128.64 and a two-hundred day moving average of $115.36. The company has a current ratio of 1.67, a quick ratio of 1.30 and a debt-to-equity ratio of 0.19. The firm has a market cap of $33.26 billion, a P/E ratio of 48.83, a price-to-earnings-growth ratio of 2.67 and a beta of 1.08.

Xylem (NYSE:XYL) last posted its quarterly earnings data on Thursday, May 2nd. The industrial products company reported $0.90 EPS for the quarter, topping the consensus estimate of $0.84 by $0.06. Xylem had a return on equity of 8.95% and a net margin of 8.34%. The company had revenue of $2.03 billion during the quarter, compared to analyst estimates of $2 billion. During the same period in the previous year, the business earned $0.72 EPS. Xylem’s quarterly revenue was up 40.4% on a year-over-year basis. On average, analysts expect that Xylem will post 4.2 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Xylem news, CAO Geri-Michelle Mcshane sold 1,000 shares of the company’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total transaction of $122,890.00. Following the transaction, the chief accounting officer now directly owns 2,935 shares in the company, valued at $360,682.15. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, CAO Geri-Michelle Mcshane sold 1,000 shares of the company’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total transaction of $122,890.00. Following the sale, the chief accounting officer now owns 2,935 shares of the company’s stock, valued at $360,682.15. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Franz Cerwinka sold 2,408 shares of the company’s stock in a transaction on Thursday, February 8th. The stock was sold at an average price of $121.79, for a total value of $293,270.32. Following the sale, the senior vice president now directly owns 11,750 shares in the company, valued at approximately $1,431,032.50. The disclosure for this sale can be found here. 0.27% of the stock is owned by insiders.

Hedge Funds Weigh In On Xylem

Several large investors have recently bought and sold shares of the business. Vanguard Group Inc. increased its holdings in Xylem by 0.7% in the fourth quarter. Vanguard Group Inc. now owns 28,048,996 shares of the industrial products company’s stock valued at $3,207,683,000 after buying an additional 187,847 shares during the last quarter. Morgan Stanley increased its holdings in Xylem by 11.5% in the third quarter. Morgan Stanley now owns 4,528,905 shares of the industrial products company’s stock valued at $412,267,000 after buying an additional 466,911 shares during the last quarter. Invesco Ltd. increased its holdings in Xylem by 35.1% in the third quarter. Invesco Ltd. now owns 4,182,821 shares of the industrial products company’s stock valued at $380,762,000 after buying an additional 1,086,102 shares during the last quarter. Royal Bank of Canada increased its holdings in Xylem by 10.6% in the third quarter. Royal Bank of Canada now owns 3,408,200 shares of the industrial products company’s stock valued at $310,249,000 after buying an additional 327,383 shares during the last quarter. Finally, Baillie Gifford & Co. grew its holdings in shares of Xylem by 2.3% during the fourth quarter. Baillie Gifford & Co. now owns 3,066,639 shares of the industrial products company’s stock worth $350,701,000 after purchasing an additional 69,619 shares during the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.